Cytrx Corp (NASDAQ:CYTR)

CAPS Rating: 2 out of 5

A biopharmaceutical research and development company engaged in developing human therapeutic products based primarily upon its small molecule molecular chaperone co-induction technology.

Recs

0
Player Avatar fwwannabees (< 20) Submitted: 11/15/2007 5:13:40 PM : Outperform Start Price: $20.44 CYTR Score: -77.71

really new technology with a nobel prize winner on the board of directors

Featured Broker Partners


Advertisement